Clinical Trials Directory

Trials / Unknown

UnknownNCT02189538

Effect of n-3 PUFA From Fish in Enteral Nutrition of Major Burn Patients

Effect of Omega-3 PUFA From Fish in Major Burn Patients. EFECTO DE ÁCIDOS GRASOS POLIINSATURADOS OMEGA 3 DERIVADOS DE ACEITE DE PESCADO, EN QUEMADOS GRAVES

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Centro Nacional de Quemados, Uruguay · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Studies have shown that burn patients may benefit from low fat diets, but there is still no strong data regarding the impact of fatty acid composition used for feeding. The trial test the hypothesis that the inclusion of omega-3 PUFA in a low fat diet may improve outcome. Prospective randomised controlled trial in adult patients admitted for burns \> 15% body surface area (BSA), and inhalation injury requiring mechanical ventilation and enteral nutrition. On admission randomization to receive a low-fat (18% energy as fat) modular enteral diet (LF-EN) and identical with the half of fat provided by fish oil (FO-EN). Study endpoints: mechanical ventilation time, inflammation (CRP), infectious and other complications, mortality until discharge. The study is planed as 2 parts: 1) preliminary study testing the feasibility of the study, 2) the study completed with information from the preliminary phase, both phases being randomised and controlled.

Detailed description

Randomisation within the first 24 hours of admission to 2 types of enteral feeds: 1) ω 3 PUFA (FO-EN) or 2) control solution which is the hospitals standard low 18% fat containing solution. The patients are fed as long as clinically required with the initial solution.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTω-3 PUFAThe patients are fed as long as the clinically required with the randomly attributed enteral solution.
DIETARY_SUPPLEMENTLow fat enteral dietThe patients are fed as long as the clinically required with the randomly attributed enteral solution

Timeline

Start date
2013-01-01
Primary completion
2017-12-01
Completion
2018-02-01
First posted
2014-07-14
Last updated
2017-02-15

Locations

1 site across 1 country: Uruguay

Source: ClinicalTrials.gov record NCT02189538. Inclusion in this directory is not an endorsement.